Issue of new ordinary shares

RNS Number : 9556J

The MedicX Fund Limited

07 July 2011

 



For immediate release                                                                                                          7 July 2011

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Issue of new ordinary shares

MedicX Fund (LSE: MXF), the specialist primary care infrastructure investor in modern, purpose-built, primary healthcare properties in the United Kingdom, announces that on Thursday 7 July 2011 it made an application for 1,500,000 new ordinary shares of no par value in the Company (the "New Shares") to be admitted to the Official List of the UK Listing Authority and admitted to trading on the Main Market of the London Stock Exchange ("Admission").  It is expected that Admission will become effective on 8 July 2011, at which point the New Shares will be issued for cash at a price (before expenses) of 78.25 pence per share.

The net proceeds will be used in further pursuing the investment objectives of the Company.

Following this issue, the Company will have 192,470,029 ordinary shares in issue.

End

For further information please contact:

MedicX Group:                                                               [phone]

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

Collins Stewart Europe Limited:                                       [phone]

Andrew Zychowski/Helen Goldsmith

Buchanan Communications:                                             [phone]

Charles Ryland/Suzanne Brooks

MedicX Fund:                                                                 [phone]

David Staples, Chairman

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 59 properties.

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 31 people operating across the UK.  

The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

END

 

 

MSCZMGGNRNMGMZG